Belinda von Niederhaeusern, PhD, has extensive experience in patient partnership and clinical research. Belinda has held various roles in companies such as Roche and DHC, focusing on patient engagement and innovative solutions. With a background in biochemistry and health policy, Belinda's main interests lie in patient-centricity, digitalization of research, and value creation in academic research.
April 1, 2024 - present
April, 2021
January, 2021
January, 2020
May, 2018